Norfloxacin Prices

Norfloxacin Price Trend, Index and Forecast

Track the latest insights on norfloxacin price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Norfloxacin Prices Outlook Q2 2025

• USA: US$ 39650/MT
• India: US$ 34580/MT
• Germany: US$ 42970/MT
• China: US$ 34850/MT
• Brazil: US$ 38810/MT

Norfloxacin Price Chart

Get real-time access to monthly/quaterly/yearly prices, Request Sample

During the second quarter of 2025, the norfloxacin prices in the USA reached 39650 USD/MT in June. In the USA, norfloxacin prices were influenced by steady demand from the pharmaceutical sector, particularly in the production of antimicrobial formulations. Feedstock costs for intermediates derived from petrochemicals added pressure on manufacturing economics, while compliance with stringent regulatory and quality standards elevated production expenses. Import dynamics for certain raw materials, combined with international shipping charges and port handling fees, further shaped procurement costs. Domestic logistics, including warehousing and distribution to hospitals and pharmacies, also contributed to overall pricing.

During the second quarter of 2025, norfloxacin prices in India reached 34580 USD/MT in June. In India, norfloxacin prices were shaped by strong demand from the generic pharmaceutical manufacturing sector, which plays a vital role in both domestic supply and export markets. Feedstock availability for intermediates was affected by petrochemical industry output, while energy and labor costs added to production overheads. Export obligations to Africa and Southeast Asia created supply-side constraints. Additionally, regulatory compliance under national quality standards and inland transportation costs significantly impacted procurement expenses.

During the second quarter of 2025, the norfloxacin prices in Germany reached 42970 USD/MT in June. In Germany, norfloxacin prices were influenced by demand from the pharmaceutical sector and dependence on imports of raw materials from Asia. Feedstock supply for intermediates and reagents was affected by global petrochemical trade dynamics, while strict environmental and quality regulations under the European Union framework added compliance costs. Energy expenses remained a major factor in production economics, and intra-European logistics, including trucking and warehousing, contributed significantly to distribution costs across the region.

During the second quarter of 2025, the norfloxacin prices in China reached 34850 USD/MT in June. In China, norfloxacin prices were shaped by the scale of domestic pharmaceutical manufacturing and the country’s role as a major exporter of active pharmaceutical ingredients. Feedstock availability for intermediates was directly linked to petrochemical production and refining activity, while energy and utility costs influenced manufacturing expenses. Export flows to Europe, North America, and Southeast Asia created external demand pressures. Domestic logistics, alongside regulatory compliance for both local and export markets, added further cost layers to the supply chain.

During the second quarter of 2025, the norfloxacin prices in Brazil reached 38810 USD/MT in June. In Brazil, norfloxacin prices were impacted by demand from the healthcare and pharmaceutical sectors, coupled with reliance on imports for key intermediates. International shipping rates and port handling charges significantly influenced procurement costs, while currency fluctuations against major trading partners added volatility. Domestic production expenses, including energy and labor costs, also shaped the market. Distribution challenges across Brazil’s vast geography further elevated logistics expenses, contributing to higher supply chain pressures.

Norfloxacin Prices Q2 2023

• USA: US$ 37,027/MT
• India: US$ 33,355/MT
• Germany: US$ 39,750/MT

The price of norfloxacin in the United States for Q2 2023 reached 37,027 USD/MT in June. Similarly, the norfloxacin prices in China settled at 33,355 USD/MT at the end of Q2 2023. The price of norfloxacin in Germany for Q2 2023 reached 39,750 USD/MT in June.

Regional Coverage

The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the norfloxacin prices.

Global Norfloxacin Price Trend

The report offers a holistic view of the global norfloxacin pricing trends in the form of norfloxacin price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price levels but also provides insights into historical price of norfloxacin, enabling stakeholders to understand past fluctuations and their underlying causes. The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed norfloxacin demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Norfloxacin Price Trend

Q2 2025:

As per the norfloxacin price index, European norfloxacin prices were shaped by steady demand from the pharmaceutical sector, particularly in the production of generic antibiotics. Dependence on imports of intermediates and active pharmaceutical ingredients from Asia left the market sensitive to global trade dynamics, shipping costs, and port handling fees. The European Union’s strict regulatory framework added compliance-related expenses, while elevated energy prices influenced manufacturing overheads. Domestic distribution through complex regional logistics networks further added to supply chain costs.

Q2 2023:

European norfloxacin prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed norfloxacin price information for a comprehensive list of countries.

North America Norfloxacin Price Trend

Q2 2025:

As per the norfloxacin price index, in North America, prices were impacted by strong requirements from the healthcare sector, especially for hospital supply and retail pharmaceuticals. Limited local production of raw materials meant reliance on imports, making procurement sensitive to currency fluctuations and international freight charges. Manufacturing costs were influenced by utility and labor expenses, while adherence to stringent regulatory and quality standards added compliance burdens. Inland distribution, including trucking and warehousing, also contributed significantly to overall supply chain dynamics.

Q2 2023:

The analysis of norfloxacin prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific norfloxacin historical data within the United States and Canada can also be provided.

Middle East and Africa Norfloxacin Price Trend

Q2 2025:

As per the norfloxacin price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences. A tight supply from refineries, exacerbated by maintenance rounds and unplanned outages, put pressure on prices. Simultaneously, demand from the agrochemical sector during the planting season contributed to price changes.

Q2 2023:

The report explores the norfloxacin pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on norfloxacin prices for countries can also be provided.

Asia Pacific Norfloxacin Price Trend

Q2 2025:

In Asia Pacific, norfloxacin prices were influenced by robust pharmaceutical production in China and India, which dominate global supply. Feedstock availability from petrochemical-based intermediates shaped manufacturing costs, while domestic energy and labor expenses further influenced production economics. Export flows to Europe, North America, and Africa created demand-side pressures, while logistics expenses for both inland transport and international shipping added to costs. Regulatory compliance for diverse export markets also contributed to higher production and certification requirements.

Q2 2023:

The norfloxacin pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This norfloxacin price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Norfloxacin Price Trend

Q2 2025:

In Latin America, particularly Brazil, norfloxacin prices were affected by a combination of domestic healthcare demand and reliance on imports for intermediates. International shipping charges, port congestion, and customs clearance procedures were major factors shaping procurement costs. Currency volatility against the US dollar added further complexity to sourcing expenses. Domestic manufacturing faced challenges from high energy and labor costs, while long-distance inland distribution within Brazil’s extensive geography significantly influenced supply chain costs.

Q2 2023:

The analysis of norfloxacin prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Norfloxacin Price Trend, Market Analysis, and News

IMARC's latest publication, “Norfloxacin Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the norfloxacin market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of norfloxacin at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed norfloxacin prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting norfloxacin pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

Norfloxacin Industry Analysis

The global norfloxacin market size reached USD 11.66 Billion  in 2024. By 2033, IMARC Group expects the market to reach USD 16.74 Billion, at a projected CAGR of 3.90%  during 2025-2033.

• The stricter environmental laws, which have led to a greater use of norfloxacin due to its effective antibacterial properties and reduced risk of resistance development, are boosting the market share.
• The norfloxacin demand is further amplified by its utilization as a treatment in healthcare sectors for bacterial infections, especially in urinary tract infections and certain sexually transmitted diseases.
• Norfloxacin is also becoming increasingly popular in the pharmaceutical sector as a critical component for managing gastroenteritis and infections caused by bacteria resistant to older antibiotic classes.
• The norfloxacin market share is further being reinforced by the development of advanced formulations that enhance its absorption and patient compliance.
• In addition, norfloxacin production is showing an upward trajectory as a result of its growing use in combating bacterial pathogens that are showing resistance to traditional antibiotics.
• The market share is also expanding due to norfloxacin's increased demand in healthcare sectors, owing to the rise in bacterial infection rates driven by global increases in travel and urbanization.
• Norfloxacin production has also witnessed a considerable surge due to widespread investment in the pharmaceutical sector, aiming at expanding the reach of effective antibacterial agents.
• A positive trend for the market is also being created by the increased use of norfloxacin in various therapeutic regimes due to its broad antibacterial spectrum and preferred safety profile in specific populations.
• The market is also expanding due to technological developments in drug delivery systems that are raising overall treatment efficacy and lowering side effects, which results in competitive pricing.
• Another factor driving norfloxacin consumption across the globe is the growing government support for its use in public health programs through subsidies and inclusion in essential medicines lists.

Norfloxacin News

The report covers the latest developments, updates, and trends impacting the global norfloxacin market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in norfloxacin production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the norfloxacin price trend.

Latest developments in the norfloxacin industry:

• May 20, 2024: Janssen Pharmaceuticals announced results from the Phase 3 QUASAR Maintenance Study (Abstract #759), demonstrating that 50.0 percent of patients with moderate to severe ulcerative colitis (UC) treated with subcutaneous (SC) TREMFYA® (guselkumab) 200 mg every four weeks achieved clinical remission at Week 44, significantly higher than the placebo group (18.9 percent).
• April 25, 2024: Merck KGaA, a leading science and technology company, is investing more than € 300 million in a new research center at its global headquarters in Darmstadt, Germany. In the Advanced Research Center, the Life Science business sector will research solutions for manufacturing antibodies, mRNA applications and additional products required for biotechnological production, among other things. As of the start of 2027, it will provide space for around 550 employees.

Product Description

Norfloxacin is a synthetic chemotherapeutic antibiotic that is boxed and sold under different brand names, such as Noroxin, under the drug class of fluoroquinolone. The first release of the drug was in the 1980s, and the purpose it serves is fighting bacterial infections by stopping DNA bacteria replication. Norfloxacin acts by being counterproductive to the activity of bacterial DNA gyrase and topoisomerase IV enzymes, which participate basically in bacterial DNA replication, transcription, repair, and recombination.

The inhibition process indicates that DNA functioning is spoiled so that the bacterial cells cannot replicate and are killed. The drug more effectively acts on Gram-negative bacteria, while it has less effect on Gram-positive ones. The drug is potent with urinary tract pathogens and hence preferred for uncomplicated urinary tract infections. Besides, it is considered effective in chronic bacterial prostatitis due to good penetration of the prostate.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of norfloxacin pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting norfloxacin price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The norfloxacin price charts ensure our clients remain at the forefront of the industry.